Teladoc Health, Inc. TDOC
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 30.78% | 39.05% | -153.90% | 49.21% | -51.58% |
| Total Depreciation and Amortization | -0.58% | -0.69% | -6.52% | 20.25% | -1.34% |
| Total Amortization of Deferred Charges | 0.00% | -3.65% | -2.86% | -7.19% | -4.65% |
| Total Other Non-Cash Items | 22.91% | -25.30% | 54.79% | -70.68% | 107.03% |
| Change in Net Operating Assets | 25,804.67% | 100.30% | -968.89% | -82.92% | 78.46% |
| Cash from Operations | 64.64% | 579.51% | -89.15% | -11.61% | 8.57% |
| Capital Expenditure | -30.82% | 44.10% | 36.62% | -14.87% | -79.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | -2,292.22% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 27.19% | -16.64% | -9.97% | -6.24% | 48.32% |
| Cash from Investing | 25.89% | -13.88% | -6.42% | 29.56% | 18.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -52.34% | 119.30% | -63.83% | 113.35% | -25.72% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -284,900.00% | 100.02% | -- |
| Cash from Financing | -52.34% | 135.73% | -321.83% | 130.73% | 99.35% |
| Foreign Exchange rate Adjustments | -45.99% | 62.18% | -389.29% | 195.06% | -107.22% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 220.04% | 177.80% | -155.34% | 17.60% | 109.08% |